Contact Us

Murli Krishna Pharma Pvt. Ltd. (MKPPL) first made its foray into the field of Pre – Finished Formulations in 2005. It laid its foundation based on the following principles:

• Strict adherence to quality policy and systems
• Toed the Regulatory guidelines
• Nurturing novel and innovative processes that would be patent non infringing, bio equivalent and based on low impurity profile
• Ensuring price competitive pre-finished formulations that require minimal or no operations

Since then, over the last decade, it has grown as a company and is now regarded as one of the strong contenders in the field of Novel Drug Delivery Systems. Besides clearing the GMP Audits from the European Union, Jordanian FDA and WHO; MKPPL had successfully cleared the customer audits from some of the major generic players which includes Pfizer, Sanofi, Novartis, Mylan etc.

As a global manufacturer of formulations, the vision and leadership of those at the helm is critical to its success. With a State-of-the-art manufacturing facilities with software which adheres to 21 CFR part Xl compliance, the management, technical and support team have achieved exceptional levels of productivity and success in product development, quality control, quality assurance and all other aspects of business and operations.

At MKPPL we implement research and development initiatives that precisely address unmet medical needs in order to contribute and improve the quality and effectiveness of medical care in the future. Our strength lies in a highly capable R&D, Quality Control-Quality Assurance system. Our R&D lab is approved by the Department of Scientific and Industrial Research, India.